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Abstract
Background: The uptake of HIV self-testing (HIVST) could address socio-structural barriers that prevent South
African youth from utilizing the testing resources available in their communities. However, to facilitate this, we must
tailor components of the HIVST kit and process to ensure that we reach and encourage youth to test. The purpose
of this study to elucidate concerns and issues regarding HIVST rollout among South African youth.
Methods: This study was conducted in two phases: 1) focus group discussions with rural, South African youth aged
18–24 and 2) direct observations of participants completing with an oral HIVST kit and/or a blood based HIVST kit.
In phase 2a participants were invited to try both an oral and blood-based HIVST kit. In phase 2b, participants
selected the HIVST kit of their choice.
Results: We enrolled 35 unique participants in phase 1, 20 participants in phase 2a, and 40 participants in phase
2b. While the focus group discussions highlighted hypothetical HIVST use only, participants appreciated the privacy
that the HIVST could afford them. However, they expressed concerns about whether HIVST could be trusted due to
false positives and negatives, as well as whether a person would be able to emotionally handle the results if they
tested alone. They suggested that the kits be used alongside someone who could provide support. In phases 2a
and 2b, participants were overwhelmingly positive about both kits regarding ease of use and whether their results
could be trusted. The participants, however, experienced more challenges with the blood-based versus oral test.
When given the choice in phase 2b, most participants (80%) chose the oral HIVST over the blood-based HIVST.
Conclusions: During the focus group discussions, participants raised concerns about the validity of HIVST, lack of
emotional support when testing alone, and the cost of HIVST kits, all of which could be addressed through current
testing campaigns. Most of those who actually tested had positive experiences with HIVST and would recommend
it to their friends. When offered a choice, most preferred the oral test.
Trial registration: NCT03162965, registered 19th May 2017.
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Background
South Africa continues to be disproportionately burdened
by the HIV pandemic, with over 6.4 million individuals cur-
rently living with the virus [1]. In 2010, the South African
government launched a large-scale, HIV testing campaign
that resulted in a reported increase in annual HIV testing
from 50% in 2008 to 66.5% in 2014 [2]. Despite this suc-
cessful outcome, there are a significant number of people
who have not tested recently [2], demonstrating that
current efforts to reach UNAIDS and country targets to re-
duce transmission rates are insufficient. Moreover, the pro-
portion of adolescents accessing HIV testing services has
been low, with youth (15–24 years) being less likely to test
than adults (25–49 years), indicating that many at high risk
for infection are unaware of their HIV status [1].
Lack of awareness of one’s HIV status drives forward HIV
transmission and leads to treatment delays [3, 4]. It is,
therefore, critical that we improve testing uptake and re-
duce the number of undiagnosed cases of HIV. To do this,
we must expand delivery options that have the potential to
overcome current barriers to HIV testing, including stigma,
discrimination, and breach of confidentiality [5]. HIV
self-testing (HIVST) is one such option that may increase
both HIV testing uptake and frequency, as well as improve
early diagnosis, all of which are linked to decreased
HIV-related morbidity, mortality, and transmission [6–10].
HIVST kits, which are available for use, sale and
distribution in a number of Western countries, as well
as in some parts of Africa (i.e., Kenya, South Africa,
Nigeria) and Brazil, enable individuals to perform a
rapid HIV antibody test on their own [11]. This could
address socio-structural barriers associated with testing,
including concerns regarding confidentiality and health-
care access [12, 13]. Additionally, HIVST may ameliorate
stigma around HIV testing, a formidable barrier [13].
While previous research in South Africa and elsewhere
have demonstrated the acceptability of HIVST among
South African adults, more youth-focused research is
needed to develop a better understanding of the nuances
of HIVST that could impact uptake [7, 14–16]. This infor-
mation is critical, as it sheds light on how strategies aimed
at linking youth to care will work outside a clinic setting,
allowing us to implement and replicate the results of suc-
cessful trials. In this study, we aimed to elucidate concerns
and issues regarding HIVST rollout, including acceptabil-
ity of HIVST among South African youth; usability of
HIVST kits; preference for blood or oral-based HIVST
kits; and recommendations that would help to facilitate
HIVST use in their communities. This information was
used to inform a randomized trial [17].
Methods
We conducted formative research to inform the Testing
Innovations study, a randomized trial designed to assess
whether offering HIVST would increase testing uptake
among young women and their peers and partners in the
Agincourt Health and socio-Demographic Surveillance
Site (HDSS) in rural Mpumalanga Province. The study
was conducted in two phases in late 2015 and early 2016:
1) formative focus groups and 2) direct observations of
participants. Regarding our phase 1 focus groups, we
sought to determine whether HIVST was acceptable to
members of the target population. We conducted four
semi-structured, focus groups that were comprised of ser-
ostatus unknown men and women between the ages of 18
and 24. Two experienced fieldworkers led the focus group
discussions using an interview guide developed by the
study team (See Additional file 1). For phase 2, we con-
ducted direct observations of self-reported HIV-negative
men and women, ages 18–24, completing both the saliva/
oral and blood test (phase 2a) or selecting which testing
they would prefer to take, either the saliva or the blood
test (phase 2b) to better understand any challenges with
self-testing and the associated materials. Convenience
sampling was used in phases 1 and 2 to recruit partici-
pants from venues in the community frequented by youth
in the target demographic.
In phase 2a, we recruited local youth to use the
HIVST kits in the presence of a trained counselor in a
private room. We asked the participants to try two dif-
ferent self-testing kits, a blood-based test and oral HIV
test. Participants were given a set of written instructions
that provided step-by-step guidance on how to use the
test kits in English and Shangaan. HIV counselors first
showed the participants how to use the HIVST kits cor-
rectly by following the instructions provided but did not
actually complete a self-test. Participants then conducted
HIVST independently, with counselors observing and
documenting whether the participants followed the in-
structions using a standardized observation checklist. At
the conclusion of the HIVST, counselors confirmed the
participant’s interpretation of the results. Participants
then responded to a brief questionnaire administered via
Computer Assisted Personal Interview (CAPI) that in-
quired about their experiences using the test kits (e.g.
clarity of instructions, comfort using the test, confidence
in test result, difficulty performing the test and reading
results). In phase 2b, procedures mirrored those of phase
2a with one exception; the participants only completed
one HIVST of their choice, either the blood-based test
or the oral test. Participants in phases 2a and 2b did not
overlap. Participants were referred to a local clinic for
confirmatory testing.
Data analysis
Focus group discussions were translated and transcribed
and imported into Atlas.ti, version 7 for data analysis. We
used a qualitative content analytic approach to analyze
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transcripts, inductively [18]. To create the coding manual,
we compared the interview transcripts and then catego-
rized common responses. A single analyst coded the tran-
scripts using agreed upon codes and created data
reduction tables to identify themes and sub-themes re-
lated to the structural codes, noting the frequency of those
themes and sub-themes, and highlighting illustrative
quotes. Ultimately, themes were developed based on pat-
terns and topics that persisted throughout the interviews.
We used SAS 9.4 to perform descriptive analysis of ques-
tionnaire data. We calculated means or medians for con-
tinuous variables and frequencies for categorical variables.
Results
Participants
Phase 1: Focus group discussions
Tables 1 and 2 summarize the participants’ demographic
characteristics. In phase 1, there were 35 participants, 19
young men (medianage = 22, interquartile range: 4) and
16 young women (medianage = 18.5, interquartile range:
3). There were 8 participants in each female focus group
and 9–10 participants in each male focus group.
Phase 2a: Observation of both oral and blood-based test
During phase 2a, there were 20 participants, 10 young
men (medianage = 19, interquartile range = 4) and 10
young women (medianage = 21, interquartile range = 2),
who completed both a blood test and a saliva test. One
participant was suffering from a dry mouth and could
not produce enough saliva to collect a sample. Prior to
study participation, 10% (n = 2) had never tested for
HIV. Of the remaining participants, 65% (n = 13) re-
ported testing for HIV in the past 6 months. The major-
ity last tested at a clinic (78%, n = 14), with a smaller
proportion testing at a non-government organization
(NGO; 22%).
Phase 2b: Observation of either oral or blood-based test
During phase 2b, a total of 40 participants (50% female;
medianage = 21) completed the HIV self-test of their
choice. One participant, however, was unable to
complete the saliva test, stating that he did not under-
stand the instructions. Prior to study participation, 18%
of participants had never been tested for HIV. Of the
remaining participants, 33% reported testing for HIV in
the past 6 months. The majority last tested at a clinic
(61%) followed by a NGO (24%), followed by testing as
part of previous research studies (12%) or private doctor
(3%). Our results indicated that the most frequently ob-
served errors occurred during the saliva test, as a number
of participants failed to read the instructions (n = 9, 28%)
or did not remove test tube cap before placing the tube in
the stand provided in the saliva test kit (n = 7. 22%). In all
cases, except one, participants and observers were con-
cordant in their interpretation of the test result. In the
only discordant observation, a participant interpreted the
blood test result as negative and the observer interpreted
it as positive. The observer noted that the participant did
not see the second line indicating a positive result.
HIVST acceptability
Overall, our results indicated that HIVST was acceptable
to study participants in both phases 1 and 2. We identi-
fied several themes that elucidate positives and negatives
about HIVST that are summarized in Table 3 and re-
ported below.
Testing independently
Focus group participants reported that HIVST would en-
able them to have more control over disclosing their sta-
tus to others due to the increased confidentiality that the
test would afford them. Similarly, participants from phase
2a cited the ability to complete the test independently as a
primary incentive for engaging in HIVST, followed by the
Table 1 Participant demographics
Phase 1 (%) Phase 2a (%) Phase 2b (%)
Gender
Male 19 10 20
Female 16 10 20
Age (Median, interquartile
range)
19, 4 21, 2 21, 2
Highest level of education
Primary – 1 (5) 1 (3)
Secondary – 7 (35) 14 (35)
Matric – 10 (50) 14 (35)
Tertiary – 2 (10) 11 (28)
Paid work in the past 6 months?
Yes – 3 (15) 4 (10)
No – 17 (85) 36 (90)
When was the last time you were tested for HIV before today?
Within the last 6 months – 13 (65) 13 (33)
6–12 months – 1 (5) 11 (28)
> 1–2 years – 3 (15) 7 (18)
> 2–5 years – 1 (5) 2 (5)
I never tested for HIV
before today
– 2 (10) 7 (18)
Where did you last test for HIV?
At the clinic – 14 (77) 20 (61)
At an NGO – 4 (22) 8 (24)
At a private doctor – 0 1 (3)
As part of a study – 0 4 (12)
Note: Percentages exceed 100% due to rounding; Two people did not provide
responses to the last question in phase 2a
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Table 2 Participant HIVST Kit Experiences
Phase 2a Phase 2b
Oral fluid n = 20 (%) Finger stick n = 20(%) Oral fluid n = 32(%) Finger stick n = 8(%)
Did you complete the HIV test today?
Yes 20 (100) 20 (100) 31 (97) 8 (100)
No – – 1 (3) –
Were you able to collect the sample?
Yes 19 (95) 20 (100) – –
No 1 (5) – – –
How comfortable did you feel collecting your own sample with the test kit?
Very comfortable 16 (84) 14 (70) 24 (77) 6 (75)
Somewhat comfortable 3 (16) 4 (20) 6 (19) 2 (25)
Somewhat uncomfortable – 2 (10) 1 (3) –
How much pain did you feel when you collected your sample with the test kit?
No pain 19 (100) 17 (85) 31 (100) 8 (100)
Not a lot of pain – 1 (5) – –
A little pain – 2 (10) – –
How easy or difficult was it to collect your sample with the test?
Very easy 18 (95) 12 (60) 29 (94) 7 (88)
Somewhat easy 1 (5) 5 (25) 2 (6) 1 (13)
Somewhat difficult – 3 (15) – –
Most difficult part
Too many steps/too complicated – 1 – –
Have a hard time with blood – 2 – –
How easy or difficult was it to conduct the test once you had collected the sample?
Very easy 18 (95) 13 (65) 27 (87) 7 (88)
Somewhat easy 1 (5) 7 (45) 4 (13) 1 (13)
How easy or difficult was it to interpret the test results – in other words – to know if the test was positive or negative?
Very easy 18 (95) 18 (90) 31 (100) 8 (100)
Somewhat difficult 1 (5) 2 (10) – –
Do you trust the test result, meaning do you believe the result?
Yes 19 (100) 20 (100) 31 (100) 8 (100)
How confident are you that you used the test correctly?
Very confident 17 (89) 11 (55) 29 (94) 7 (88)
Somewhat confident 2 (11) 5 (25) 2 (6) 1 (13)
Somewhat unconfident – 4 (20) – –
How confident are you that you could use the test correctly in the future on your own?
Very confident 19 (95) 20 (100) 31 (100) 8 (100)
Somewhat confident 1 (5) – – –
Take a moment to think about when you used the HIV test. What did you like most about the test? (Please pick your top answer)
Trusted that results were accurate – 3 (15) 1 (3) –
That the test was easy to use 4 (20) 5 (25) 8 (26) 1 (13)
That the test was comfortable to use 2 (10) 1 (5) 1 (3) 1 (13)
That I could do the test myself 14 (70) 10 (50) 19 (61) 5 (63)
It was a new way to test for HIV – 1 (5) 1 (3) 1 (13)
It used saliva to test for HIV – – 1 (3) –
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test being easy to use. Participants in phase 2a also re-
ported more comfort with collecting saliva samples than
they were collecting blood samples (Table 1). During
phases 2a and 2b, almost all participants reported that it
was very easy to collect the saliva sample (95 and 94%, re-
spectively). Moreover, all participants were very confident
that they could use the test independently and the over-
whelming majority reported that, if they were to be tested
for HIV again, they would prefer to use a HIVST kit at
home (2a: 100%; 2b: 80%). Despite this, slightly more than
half of the participants in 2a and some participants (19%)
in 2b reported that they would like to have someone (e.g.,
a family member (n = 4) or sexual partner or a friend (n =
1), respectively), with them at home while engaging in
HIVST. These findings are consistent with some of the re-
sponses from the focus groups, during which some partic-
ipants expressed the importance of testing with either a
close friend or relative to provide immediate access to so-
cial support. This sentiment, however, was not universal,
as others expressed skepticism about testing with friends
and suggested that the desire to test with others, whether
friends or relatives, was dependent upon the quality of the
relationship and interpersonal trust.
User preferences
Preferences for type of kit
Focus group participants expressed preferences regard-
ing the type of HIVST (i.e., saliva or blood-based) de-
pending upon their key concerns about HIVST overall.
Specifically, we found that participants who reported
concerns about potential pain during HIVST showed a
preference for the saliva-based test, while those most
concerned about accuracy preferred the blood-based
test. During phase 2a, most participants reported that
they were very comfortable using the saliva test (84%),
that it was painless (100%), and very easy to collect the
sample and use the test (95%). During 2b most partici-
pants chose the saliva test (80%), reporting that they
were very comfortable using the saliva test (77%), that it
Table 2 Participant HIVST Kit Experiences (Continued)
Phase 2a Phase 2b
Oral fluid n = 20 (%) Finger stick n = 20(%) Oral fluid n = 32(%) Finger stick n = 8(%)
What did you like least about the test?
Fear of Pricking – 3 (15) – –
Test was Painful – – – 1 (13)
Waiting Time – – – 1 (13)
There was nothing I disliked about the test 20 (100) 17 (85) 31 (100) 6 (75)
For your next HIV test, would you prefer to go to the clinic or test yourself at home?
Health Worker – – 8 (20) –
Do it yourself at home 20 (100) – 32 (80) –
If you would prefer to test yourself at home, would you like someone to be there with you?
Yes 11 (55) – 6 (19) –
No 9 (45) – 26 (81) –
If you would like to have someone with you, who would you like to be there?
A friend – – 1 (17) –
A family member – – 4 (67) –
A sexual partner – – 1 (17) –
If HIV self-test kits were available (like the one you used today), how likely is it that you would use one to test yourself for HIV?
Very likely 18 (90) – 40 (100) –
Somewhat likely 1 (5) – – –
Somewhat unlikely 1 (5) – – –
If both tests (blood and saliva) were available in the future, which would you likely pick?
Blood 6 (30) – 11 (28) –
Saliva 11 (55) – 29 (72) –
No preference, I like both 3 (15) – – –
How much would you pay for this HIV test kit (oral or blood, respectively)?
Range 10–200 10–300 0–300 –
Note: - indicates that the question was not asked or applicable, or that the response was zero
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was painless (100%), and very easy to collect the sample
(94%) and use the test (87%).
Where to test
Phase 1 focus group participants were asked to provide
suggestions regarding places where a youth might feel
comfortable engaging in HIVST. While most partici-
pants agreed that a bathroom or private bedroom
would be the best place to take the test, a number of
participants noted concerns. Participants, for example,
suggested that these places might not be feasible for
youth in their communities, as many share bathrooms
and bedrooms with others and may not be afforded
much privacy. As such, participants suggested that a
degree of creativity (i.e., HIVST booths at convenient
sites within the community) or pre-planning was essen-
tial to make time to test.
Materials accompanying the test kit
Participants were asked to share their thoughts and rec-
ommendations regarding the types of materials that
should be included in the HIVST kits. For both test kits,
participants in the phase 1 focus groups suggested that
the kits include pre- and post-test counseling materials
(e.g., pamphlets or resource lists), or provide a toll-free
number where an individual is able to receive free
Table 3 Overview of participants responses
Themes Illustrative Quotations
HIVST acceptability
Testing independently “It is good because [HIVST] could reduce the rates of HIV because [some people] are afraid to be tested by other people. It
is a good idea because a person will test alone and get the result alone… It’s good because you test at home. If you test
positive, no one will know. You will keep it to yourself until you get ready to disclose… It is good for me because my
status will be known by me only, if it happens that other people know, it would be me who disclose.” (22-year-old male)
“I am very close to my best friend, so I would like to be with her when I do the test”(20-year old male)
“I cannot tell my best friend, because she has secrets she don’t tell me some of the things about her life, so why should I
have to tell her or be with her, it means she don’t trust me so why should I have to trust her, so I will tell one of my
brother from the church, I trust him so much.” (18-year-old female)
User preferences
Preferences for type of kit “I won’t tell my friends to use this test [blood based test] because they can feel the pains after using it. The saliva is better
though the time to wait for the results is longer than this blood test. The main thing is getting the proper results as it is
easy because you swab the saliva only.” (22-year-old male)
“…We learned that HIV test can be easily be detected through blood or blood contamination. So now we are told that
we can use saliva to test HIV. I don’t understand now. That is why people will prefer this blood test. It is the best.” (22-
year-old male)
Where to test Interviewer: “Do you think people of your age may have challenges in finding a place to do the test?”
P14: “They will have difficulties”. (20 years old)
I: “Where would they think they can do the test?”
P18: “They can do it in their rooms.” (20 years old)
P10: “At home sometimes we don’t have enough rooms we share our rooms. It would be better if there is a place like a
voting station where we can do our test in private so that everyone will know their status alone. And there should be a
dust bin there to throw rubbish in.” (18 years old) (male focus group)
“Just create your own time, and to the test, use the little chance you get. Especially when you bath no you will take your
time, people might think that you are bathing.” (21-year-old female)
Materials accompanying
the test kit
“There should be a pamphlet in the kit that explains that has counselling message like written life goes on [even if you
test positive].” (22-year-old male)
Concerns about HIVST
Validity of HIVST results “How sure are you about this kit? I don’t trust this kit. Why should I have to go back to the clinic and get tested again
after using [the HIVST kit] and [to potentially] test positive? I cannot use [the HIVST]. I’d rather go to the clinic and use
blood test, not [the blood HIVST].” (18-year-old male)
“The saliva test is not easy to me because if I test and the results are invalid, will I then go to the clinic to test again? [The
reason that] I collected the kit privately was because I wanted to test [on my own] and I don’t want the nurses to know
my status or results. So, I [don’t like HIVST]… I want the type of test that I can do alone rather than having to go to the
clinic [for confirmation].” (22-year-old, male)
Lack of emotional support “…I don’t understand this type of test because if I can find out that I am HIV positive the time I do the test privately I will
think of a lot of things because there won’t be anyone who will support me or at least [in the clinic] I get counselling that
will [tell me] what I should do if I am HIV positive because I can think of committing suicide.” (25-year-old male)
Costs of test “I think at the clinic and chemist [pharmacy] are good places because this test is also for health.” (18-year-old male)
“I don’t agree about getting the kit at the chemist because not everyone will afford it because we have to buy the kit and
mostly youth are unemployed, so they won’t get money to buy those test kit at the chemistry.” (24-year-old male)
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counseling and encouragement in the event of a positive
diagnosis. Additionally, focus group participants sug-
gested that several materials should be included in the
test kit, including wet and dry wipes to disinfect and dry
one’s finger in preparation for the prick, gloves to avoid
improperly handling the test kits, and a disposal bag to
facilitate confidentiality.
Concerns about HIVST
Validity of HIVST results
Despite the overall positive views about self-testing from
participants in phase 1, some expressed concerns. Several
focus group participants were troubled by the fact that test
results could be invalid and return false positive or nega-
tive results. These participants believed that it would then
be difficult to trust the results of HIVST, overall, and sug-
gested that participants might even attribute positive test
results to an unreliable HIVST kit rather than actually be-
ing HIV positive. Moreover, there were potential concerns
about wasting time and/or money on a HIVST that could
provide users with incorrect results or that requires a
follow-up test at the clinic anyway. This seemed to be less
of a concern for participants in phases 2a and 2b who ac-
tually had the opportunity to use the HIVST, as they
unanimously reported that they trusted their HIVST test
results. Participants did appear to have difficulties with
using the blood-based kit, as 30% of participants received
an invalid result compared to only 5% of those using the
saliva test in phase 2a. Only one participant completing a
saliva test in phase 2b received an invalid result and none
who completed the blood-based test received an invalid
result; however, significantly fewer individuals elected to
use the blood kit.
Lack of emotional support
Though participants praised the HIVST for the privacy
and confidentiality that it afforded users, a number of
participants in phase 1 expressed concerns regarding a
lack of emotional support should an individual be alone
and test positive for HIV. Participants noted that trad-
itional HIV testing in clinic settings gives patients access
to immediate and often concurrent HIV counseling. There
was uncertainty regarding how individuals would cope
with a positive test in the absence of counseling and sev-
eral believed that individuals might choose to end their
lives as a result.
Costs of test
There were also concerns about the potential costs of a
HIVST, as some participants worried about youths’ ability
to purchase HIVST kits given the high rates of unemploy-
ment amongst youth.
Discussion
We found that HIVST was both highly acceptable and
preferable to traditional clinic-based testing among
young, rural South Africans. This finding is consistent
with previous research with South African youth in
urban settings and adult men who have sex with men
[19, 20]. Moreover, as in other studies, favorable atti-
tudes toward HIVST were largely attributed to the tests’
ability to address critical barriers to HIVST, including: 1)
confidentiality, 2) privacy, 3) convenience, and 4) control
over disclosing one’s status to others [7, 14, 21]. In both
the focus group discussions and observations of HIVST
use, there was a strong preference for the saliva-based
HIVST kit over the blood-based HIVST kit, as more
participants reported that the saliva test was very easy to
use when compared to the blood test. This finding dif-
fers from a previous study in rural South Africa among
young men who have sex with men that showed a par-
ticipant preference for the blood test [22]. It is notable
that in phase 2b, almost a third of participants did not
read the instructions prior to attempting to collect a sal-
iva sample and some missed or reversed steps. This,
however, did not appear to influence their ability to col-
lect the sample. A number of youth reported that they
would prefer to complete the test in the presence of a
relative, friend, or sexual partner. These findings could
have implications for the way in which HIVST kits are
marketed, such that packaging HIVST kits in pairs could
improve HIV testing uptake and also encourage those
requiring additional support to test with a trusted com-
panion (8).
Despite the positive views about HIVST, a number of
focus group participants expressed noteworthy concerns.
First, there were concerns about the lack of social sup-
port during HIVST, particularly for those who choose to
test alone. Participants were especially concerned that a
positive test could lead a person to behave irrationally
and possibly attempt suicide. As suggested in previous
research in South Africa and elsewhere, there are links
between suicidal ideation and recent HIV diagnosis, as
well as disparities in reports of suicidal ideation or past
suicide attempts between people living with HIV/AIDS
and their counterparts [23–27]. Providing individuals
with access to both local and national resources for
counseling and support services pre- and post-HIVST
could reduce suicide risk within this population. Such
resources could include 24-h hotlines, contact informa-
tion for local mental health providers, or access to
counseling applications for mobile devices that help in-
dividuals to make decisions regarding HIV testing using
avatars suggesting that individual test in the presence
of a trusted relative or friend [26]. In this way, we can
provide further assurance that help is available to those
who need it.
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Second, some focus group participants expressed con-
cerns about the validity of saliva-based HIV tests, believ-
ing that HIV was best detected using a blood-based test,
which is consistent with previous research [20]. How-
ever, this did not diminish acceptability of self-testing
within the groups. Moreover, there were concerns about
the probability of receiving invalid test results, leading
some participants to question the accuracy of HIVST.
During phase 2a, more than a third of participants re-
ceived invalid results using the blood-based test but only
5% received invalid results using the saliva-based test. It
is possible that the manufacturer’s instructions or the
design of the blood-based kit itself requires adjustment
to improve one’s chances of obtaining valid results, as
the instructions of the blood test required multiple steps.
Test manufacturers could partner with communication
and public health experts to develop HIVST instructions
that are shorter, require fewer steps and are thus more
user friendly. Relatedly, a number of focus group partici-
pants lamented the idea of engaging in a repeat HIV test
within three months of HIVST for diagnostic verification
purposes. It is notable that HIVST kits are considered to
be screening devices and are therefore not intended to
be diagnostic. For some participants, the necessity of be-
ing tested in the clinic rendered the HIVST less useful
and suggested that it was better to be tested in the clinic
the first time around to avoid unnecessary cost and de-
mands on one’s time. Given that the primary incentive to
engage in HIVST was related to increased confidentiality
and independence, it will be critical to identify ways to
continue to protect one’s privacy during repeat HIVST.
Participants suggested that it might be difficult for youth
in their communities to find private places to engage in
HIVST. While most suggested that a private bedroom or
bathroom at home would be sufficient, some suggested
that shared and often overcrowded living conditions could
make that difficult. Youth, for example, might need to
spend 20min or more in the bathroom from start to
finish, which some participants suggested could lead to
suspicion. While there are no easy solutions for this par-
ticular challenge, most participants believed that youth
would be able to find a place to test and would be less
worried about this particular concern. Local clinics may
be helpful in this regard. Task-shifting is one possible
solution to concerns about privacy. For example, rather
than being tested by clinic staff, lay counselors could be
trained to show patients how to use the test and then
allow them to test on their own in a small private room.
Afterwards, a patient could indicate whether or not
they would be interested in additional counseling. Al-
ternatively, stakeholders could consider setting up
HIVST booths at either clinics or in public locations
(e.g., schools, churches, frequented community venues)
that could provide people with a private place to test.
Such an approach would give participants greater au-
tonomy with regard to disclosing their status to staff, as
well as in their decision to seek counseling or not.
However, it might be important that such booths serve
multiple purposes to maintain confidentiality and re-
duce stigma.
Lastly, there was concern about the potential cost of
HIVST. Those at greatest risk for HIV infection may
have significant challenges with regard to purchasing test
kits. Many, for example, are unemployed and lack basic
necessities. As a result, purchasing a HIVST kit may not
be feasible. Participants suggested that HIVST kits be of-
fered freely at local clinics or at pharmacies for reduced
costs. There are, in fact, a number of initiatives in South
Africa, as well as within other countries in sub-Saharan
Africa, testing the feasibility of wide-scale distribution of
HIVST kits [28, 29].
For those who choose to engage in HIVST, focus group
participants suggested that materials (e.g., dry wipes, glove
us, and a disposal bag) should be included in the test kit
to facilitate hygienic handling and proper kit disposal. In
rural, underserved settings, such materials may not be
readily available in one’s home. Therefore, including them
with the kit could not only relieve potential burden, but
could also help to ensure that participants do not contam-
inate the sample, which could increase the likelihood of
valid results. Despite the reservations expressed during
focus groups, acceptability remained high. Moreover,
among participants who engaged in HIVST during the pi-
lots, the feedback was overwhelmingly positive and most
reported that they would prefer to engage in HIVST in
the future. It is likely that direct experience with the test
kits helps youth to overcome initials reservations that they
may have about their ability to engage in HIVST. As such,
supervised practice and instruction prior to testing inde-
pendently might be required for some youth, particularly
those interested in the blood-based test.
There are a number of potential limitations associated
with the current study. First, we are limited by a small
sample size; as a result, we cannot guarantee that our re-
sults are generalizable beyond study participants. Sec-
ond, participants were conveniently sampled; therefore,
views expressed during focus groups and the direct ob-
servation studies may not be generalizable to all young
people. Finally, we did not confirm the HIV status of
focus group participants, which could potentially shape
views regarding HIVST.
Conclusions
Our results indicated that HIVST was highly acceptable
to young, South African male and female participants
residing in a rural community. However, a number of
concerns were raised that require attention in order to
improve HIVST uptake within this population.
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Participants overwhelmingly preferred the saliva-based
HIVST kit despite some believing that the blood-based
test was more accurate. HIVST has the potential to ad-
dress key barriers to HIV-testing in community-based
settings; however, key measures need to be taken to en-
sure that end users are provided with necessary support
resources to protect against unintended negative out-
comes, such as suicidal behavior. It is therefore critical
that researchers, product developers, and end users part-
ner to determine best approaches to HIV testing within
specific populations.
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